On Wednesday, May 31 Hoeltzel Mary T sold $460,313 worth of CIGNA Corporation (NYSE:CI) or 2,850 shares. They now have a $191.00 target price on the health services provider's stock.
July 13 investment analysts at Deutsche Bank maintained a company rating of "Buy" and raised the price expectation to $180.00 from $125.00. The stock of CIGNA Corporation (NYSE:CI) earned "Buy" rating by Citigroup on Friday, October 2.
August 17 investment analysts at Morgan Stanley kept the company rating at "Overweight" and raised the price target from $188.00 to $195.00. BidaskClub upgraded shares of Cigna Corporation from a "buy" rating to a "strong-buy" rating in a research report on Friday, August 18th. Bank of America Corporation upped their price objective on shares of Cigna Corporation from $193.00 to $198.00 and gave the company a "buy" rating in a research note on Friday, June 23rd. Three equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. Cigna Corporation now has a consensus rating of "Buy" and an average target price of $182.59. Sentry Invests holds 0.68% of its portfolio in CIGNA Corporation (NYSE:CI) for 671,200 shares. Company shares last traded at $186.05 marginally over the 50 day moving average of $179.52 and a great deal higher than the 200 day moving average of $165.10.
The P/E ratio is now 21.47 and the market cap is 46.84B.
Analysts await CIGNA Corporation (NYSE:CI) to report earnings on November, 2. The value in dollars increased from $13,667,000 to $16,071,000 a change of $2,404,000 quarter over quarter. Cigna Corporation had a return on equity of 17.40% and a net margin of 5.55%. The business had revenue of $10.32 billion during the quarter, compared to the consensus estimate of $10.26 billion. During the same quarter in the previous year, the firm posted $1.98 EPS. Cigna Corporation's revenue for the quarter was up 3.6% on a year-over-year basis. In the last earnings report the EPS was $8.67 and is estimated to be $10.02 for the current year with 251,778,000 shares now outstanding.
TRADEMARK VIOLATION NOTICE: This piece of content was published by Equities Focus and is owned by of Equities Focus. If you are reading this article on another website, it was stolen and republished in violation of United States & global copyright law. The legal version of this article can be read at https://weekherald.com/2017/09/17/piper-jaffray-companies-reiterates-buy-rating-for-cigna-corporation-ci.html.
Investors may be interested in viewing the Gross Margin score on shares of Telephone and Data Systems, Inc. About 172,796 shares traded or 50.11% up from the average. Following the completion of the transaction, the chief executive officer now owns 421,162 shares in the company, valued at approximately $71,681,772.40. The sale was disclosed in a filing with the SEC, which is available through this link.
Matthew G. Manders, Pres. Gov't & Ind Prog & Group let go of $4,262,719 worth of shares at a price of $175.01 on Friday the 21st. The shares were sold at an average price of $175.01, for a total value of $4,262,718.57. Following the transaction, the insider now owns 46,256 shares in the company, valued at $8,095,262.56. The disclosure for this sale can be found here.
Large investors have recently made changes to their positions in the business. The stock of CIGNA Corporation (NYSE:CI) earned "Outperform" rating by RBC Capital Markets on Monday, May 8.
A number of institutional investors and hedge funds have recently modified their holdings of CI. Ahl Partners Llp expanded its ownership by buying 2,713 shares an increase of 2.9% as of 06/30/2017. Triplett now owns $3,684,658 of stock as reported to the SEC.
As of quarter end Squarepoint Ops LLC had bought a total of 46,117 shares growing its stake by 75.5%. Ahl Partners Llp now owns 96,012 shares valued at $16,071,000. Howard Hughes Medical Institute's holdings in Cigna Corporation were worth $439,000 at the end of the most recent quarter. Stevens Capital Management LP bought a new position in shares of Cigna Corporation in the second quarter worth about $20,593,000. Finally, Dynamic Technology Lab Private Ltd grew its stake in shares of Cigna Corporation by 255.4% in the 2nd quarter. Dynamic Technology Lab Private Ltd now owns 6,752 shares of the health services provider's stock valued at $1,130,000 after purchasing an additional 4,852 shares during the period. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at an attractive price.
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company.